Charles Schwab’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $835K | Sell |
883,227
-267,544
| -23% | -$253K | ﹤0.01% | 2956 |
|
2025
Q1 | $530K | Sell |
1,150,771
-40,320
| -3% | -$18.6K | ﹤0.01% | 3065 |
|
2024
Q4 | $880K | Sell |
1,191,091
-226,204
| -16% | -$167K | ﹤0.01% | 2958 |
|
2024
Q3 | $2.23M | Buy |
1,417,295
+58,147
| +4% | +$91.3K | ﹤0.01% | 2678 |
|
2024
Q2 | $2.28M | Buy |
1,359,148
+478,025
| +54% | +$803K | ﹤0.01% | 2667 |
|
2024
Q1 | $2.11M | Buy |
881,123
+16,948
| +2% | +$40.7K | ﹤0.01% | 2575 |
|
2023
Q4 | $1.32M | Buy |
864,175
+12,254
| +1% | +$18.7K | ﹤0.01% | 2746 |
|
2023
Q3 | $929K | Buy |
851,921
+139,546
| +20% | +$152K | ﹤0.01% | 2824 |
|
2023
Q2 | $1.63M | Buy |
712,375
+23,764
| +3% | +$54.4K | ﹤0.01% | 2612 |
|
2023
Q1 | $1.67M | Sell |
688,611
-7,329
| -1% | -$17.8K | ﹤0.01% | 2571 |
|
2022
Q4 | $1.33M | Buy |
695,940
+33,462
| +5% | +$63.9K | ﹤0.01% | 2684 |
|
2022
Q3 | $1.59M | Buy |
662,478
+227,914
| +52% | +$547K | ﹤0.01% | 2646 |
|
2022
Q2 | $809K | Sell |
434,564
-66,564
| -13% | -$124K | ﹤0.01% | 2874 |
|
2022
Q1 | $1.05M | Buy |
501,128
+12,710
| +3% | +$26.6K | ﹤0.01% | 2830 |
|
2021
Q4 | $1.93M | Buy |
488,418
+12,624
| +3% | +$49.8K | ﹤0.01% | 2714 |
|
2021
Q3 | $2.29M | Buy |
475,794
+6,090
| +1% | +$29.3K | ﹤0.01% | 2666 |
|
2021
Q2 | $2.16M | Buy |
469,704
+46,478
| +11% | +$213K | ﹤0.01% | 2693 |
|
2021
Q1 | $2.49M | Buy |
423,226
+89,440
| +27% | +$525K | ﹤0.01% | 2601 |
|
2020
Q4 | $1.14M | Buy |
333,786
+38,657
| +13% | +$132K | ﹤0.01% | 2730 |
|
2020
Q3 | $425K | Buy |
295,129
+11,235
| +4% | +$16.2K | ﹤0.01% | 2918 |
|
2020
Q2 | $567K | Buy |
283,894
+17,201
| +6% | +$34.4K | ﹤0.01% | 2780 |
|
2020
Q1 | $521K | Buy |
266,693
+3,843
| +1% | +$7.51K | ﹤0.01% | 2700 |
|
2019
Q4 | $1.09M | Buy |
262,850
+31,439
| +14% | +$130K | ﹤0.01% | 2566 |
|
2019
Q3 | $697K | Sell |
231,411
-37,503
| -14% | -$113K | ﹤0.01% | 2673 |
|
2019
Q2 | $1.69M | Buy |
268,914
+3,684
| +1% | +$23.2K | ﹤0.01% | 2423 |
|
2019
Q1 | $1.48M | Buy |
265,230
+5,729
| +2% | +$31.9K | ﹤0.01% | 2449 |
|
2018
Q4 | $1.72M | Sell |
259,501
-6,744
| -3% | -$44.8K | ﹤0.01% | 2384 |
|
2018
Q3 | $2.84M | Buy |
266,245
+25,184
| +10% | +$269K | ﹤0.01% | 2312 |
|
2018
Q2 | $2.89M | Buy |
241,061
+14,426
| +6% | +$173K | ﹤0.01% | 2254 |
|
2018
Q1 | $1.94M | Buy |
226,635
+7,078
| +3% | +$60.7K | ﹤0.01% | 2344 |
|
2017
Q4 | $2.17M | Buy |
219,557
+15,428
| +8% | +$152K | ﹤0.01% | 2277 |
|
2017
Q3 | $2.51M | Buy |
204,129
+10,811
| +6% | +$133K | ﹤0.01% | 2211 |
|
2017
Q2 | $3.18M | Buy |
193,318
+1,633
| +0.9% | +$26.9K | ﹤0.01% | 2040 |
|
2017
Q1 | $2.75M | Sell |
191,685
-122,226
| -39% | -$1.75M | ﹤0.01% | 2068 |
|
2016
Q4 | $4.34M | Sell |
313,911
-1,234
| -0.4% | -$17.1K | ﹤0.01% | 1820 |
|
2016
Q3 | $5.7M | Buy |
315,145
+9,942
| +3% | +$180K | 0.01% | 1557 |
|
2016
Q2 | $4.38M | Buy |
305,203
+152,735
| +100% | +$2.19M | 0.01% | 1649 |
|
2016
Q1 | $1.82M | Buy |
152,468
+3,375
| +2% | +$40.3K | ﹤0.01% | 2096 |
|
2015
Q4 | $1.99M | Buy |
149,093
+4,338
| +3% | +$57.8K | ﹤0.01% | 2083 |
|
2015
Q3 | $1.56M | Buy |
144,755
+13,305
| +10% | +$143K | ﹤0.01% | 2204 |
|
2015
Q2 | $1.06M | Buy |
131,450
+3,793
| +3% | +$30.6K | ﹤0.01% | 2392 |
|
2015
Q1 | $844K | Buy |
127,657
+6,219
| +5% | +$41.1K | ﹤0.01% | 2441 |
|
2014
Q4 | $774K | Buy |
121,438
+36,345
| +43% | +$232K | ﹤0.01% | 2458 |
|
2014
Q3 | $840K | Sell |
85,093
-8,681
| -9% | -$85.7K | ﹤0.01% | 2380 |
|
2014
Q2 | $1.06M | Sell |
93,774
-8,226
| -8% | -$92.7K | ﹤0.01% | 2286 |
|
2014
Q1 | $1.24M | Buy |
102,000
+2,701
| +3% | +$32.7K | ﹤0.01% | 2176 |
|
2013
Q4 | $1.25M | Buy |
99,299
+12,009
| +14% | +$151K | ﹤0.01% | 2162 |
|
2013
Q3 | $1.77M | Sell |
87,290
-33,819
| -28% | -$684K | ﹤0.01% | 1921 |
|
2013
Q2 | $1.94M | Buy |
+121,109
| New | +$1.94M | ﹤0.01% | 1774 |
|